About Nagasaki University Graduate School of Biomedical Sciences
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Japan Clinical Cancer Research Organization
1
Okayama University
1
SURPRISE Study Group
1
Clinical Trials at Nagasaki University Graduate School of Biomedical Sciences
During the past decade, Nagasaki University Graduate School of Biomedical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation
2009-10-01
2014-12-01
Completed
233
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nagasaki University Graduate School of Biomedical Sciences"
#1 collaborator was "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Nagasaki University Graduate School of Biomedical Sciences
According to Clinical.Site data, the most researched conditions in "Nagasaki University Graduate School of Biomedical Sciences" are
"Gastric Cancer" (1 trials), "Periodontitis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Nagasaki University Graduate School of Biomedical Sciences" in a lesser frequency.
Clinical Trials Intervention Types at Nagasaki University Graduate School of Biomedical Sciences
Most popular intervention types in "Nagasaki University Graduate School of Biomedical Sciences" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "S-1" (1 trials), "Tocilizumab" (1 trials), "Tocilizumab plus methotrexate" (1 trials) and "docetaxel + S-1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nagasaki University Graduate School of Biomedical Sciences
The vast majority of trials in "Nagasaki University Graduate School of Biomedical Sciences" are
3 trials for "All" genders.
Clinical Trials Status at Nagasaki University Graduate School of Biomedical Sciences
Currently, there are NaN active trials in "Nagasaki University Graduate School of Biomedical Sciences".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Nagasaki University Graduate School of Biomedical Sciences,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nagasaki University Graduate School of Biomedical Sciences, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".